AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PureTech Health plc

Transaction in Own Shares Nov 29, 2023

4932_rns_2023-11-29_a188fca3-88d1-40ce-be04-dabde551fbc8.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9671U

PureTech Health PLC

29 November 2023

29 November 2023

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase: 28 November 2023
Number of ordinary shares purchased: 39,084
Highest price paid per share: 160.20p
Lowest price paid per share: 156.20p
Volume weighted average price paid per share: 157.74p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,665,041 ordinary shares in treasury and has 272,803,118 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 272,803,118 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

Contact:

PureTech

Investor Relations

[email protected]

Individual Transactions

Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
28/11/2023 08:34:24 568 160.2 XLON 00380079201TRLO0.1.1
28/11/2023 08:34:24 1136 160.2 XLON 00380079202TRLO0.1.1
28/11/2023 08:42:57 165 160 AQXE 00380081002TRLO0.1.1
28/11/2023 08:42:57 112 159 TRQX 00380081003TRLO0.1.1
28/11/2023 08:42:58 285 158.8 CHIX 00380081010TRLO0.1.1
28/11/2023 08:42:58 515 158.8 BATE 00380081011TRLO0.1.1
28/11/2023 08:42:58 283 158.8 CHIX 00380081012TRLO0.1.1
28/11/2023 09:23:39 33 158 CHIX 00380089760TRLO0.1.1
28/11/2023 09:34:46 32 158 CHIX 00380092577TRLO0.1.1
28/11/2023 09:49:50 27 158 CHIX 00380095595TRLO0.1.1
28/11/2023 09:54:14 160 158 CHIX 00380096480TRLO0.1.1
28/11/2023 09:54:18 35 158 CHIX 00380096496TRLO0.1.1
28/11/2023 10:00:22 13 158 CHIX 00380097883TRLO0.1.1
28/11/2023 10:02:04 12 158 CHIX 00380098248TRLO0.1.1
28/11/2023 10:09:56 1 158 CHIX 00380100256TRLO0.1.1
28/11/2023 10:41:47 568 158 XLON 00380107196TRLO0.1.1
28/11/2023 10:41:47 23 158 XLON 00380107197TRLO0.1.1
28/11/2023 10:41:47 156 158 CHIX 00380107199TRLO0.1.1
28/11/2023 10:41:47 3 158 XLON 00380107198TRLO0.1.1
28/11/2023 10:41:47 294 158 BATE 00380107201TRLO0.1.1
28/11/2023 10:41:47 542 158 XLON 00380107200TRLO0.1.1
28/11/2023 10:41:47 165 157.8 AQXE 00380107203TRLO0.1.1
28/11/2023 10:41:47 515 158 BATE 00380107202TRLO0.1.1
28/11/2023 10:41:47 99 158 CHIX 00380107205TRLO0.1.1
28/11/2023 10:41:47 394 158 CHIX 00380107206TRLO0.1.1
28/11/2023 10:41:47 174 158 CHIX 00380107204TRLO0.1.1
28/11/2023 10:41:50 112 156.8 TRQX 00380107213TRLO0.1.1
28/11/2023 10:41:50 58 156.8 TRQX 00380107214TRLO0.1.1
28/11/2023 10:43:09 503 157.4 XLON 00380107426TRLO0.1.1
28/11/2023 10:43:09 508 157.6 XLON 00380107427TRLO0.1.1
28/11/2023 11:31:00 20 157.6 CHIX 00380116100TRLO0.1.1
28/11/2023 12:02:01 548 157.6 CHIX 00380120585TRLO0.1.1
28/11/2023 12:02:01 452 157.6 CHIX 00380120586TRLO0.1.1
28/11/2023 12:02:01 280 157 BATE 00380120588TRLO0.1.1
28/11/2023 12:02:01 1136 157.6 XLON 00380120587TRLO0.1.1
28/11/2023 12:02:01 235 157 BATE 00380120589TRLO0.1.1
28/11/2023 12:02:01 111 157 TRQX 00380120590TRLO0.1.1
28/11/2023 12:03:18 359 157.6 XLON 00380120878TRLO0.1.1
28/11/2023 12:35:51 33 156.4 AQXE 00380125471TRLO0.1.1
28/11/2023 13:01:20 226 157 CHIX 00380129713TRLO0.1.1
28/11/2023 13:01:20 342 157 CHIX 00380129714TRLO0.1.1
28/11/2023 14:06:40 684 158 CHIX 00380142899TRLO0.1.1
28/11/2023 14:29:13 359 158 XLON 00380148094TRLO0.1.1
28/11/2023 14:29:13 4071 158 XLON 00380148095TRLO0.1.1
28/11/2023 14:43:45 568 158 CHIX 00380157548TRLO0.1.1
28/11/2023 14:43:45 568 158 CHIX 00380157549TRLO0.1.1
28/11/2023 14:43:45 1704 158 XLON 00380157550TRLO0.1.1
28/11/2023 14:43:46 515 157.4 BATE 00380157555TRLO0.1.1
28/11/2023 14:43:46 112 157.4 TRQX 00380157556TRLO0.1.1
28/11/2023 14:43:47 350 158 AQXE 00380157569TRLO0.1.1
28/11/2023 14:44:49 277 158 AQXE 00380158058TRLO0.1.1
28/11/2023 14:44:56 899 158 XLON 00380158102TRLO0.1.1
28/11/2023 14:44:56 200 158 XLON 00380158103TRLO0.1.1
28/11/2023 14:51:34 31 158 XLON 00380161062TRLO0.1.1
28/11/2023 14:53:32 200 158 XLON 00380161667TRLO0.1.1
28/11/2023 14:56:16 200 158 XLON 00380162541TRLO0.1.1
28/11/2023 15:01:56 165 158 AQXE 00380165129TRLO0.1.1
28/11/2023 15:04:05 397 158 CHIX 00380165992TRLO0.1.1
28/11/2023 15:05:35 1130 157.8 XLON 00380166467TRLO0.1.1
28/11/2023 15:05:35 211 157.8 XLON 00380166468TRLO0.1.1
28/11/2023 15:05:35 1318 158 XLON 00380166469TRLO0.1.1
28/11/2023 15:05:40 753 157.8 XLON 00380166498TRLO0.1.1
28/11/2023 15:05:40 206 157.8 XLON 00380166497TRLO0.1.1
28/11/2023 15:05:47 223 157.8 XLON 00380166547TRLO0.1.1
28/11/2023 15:05:55 358 157.8 XLON 00380166579TRLO0.1.1
28/11/2023 16:06:59 1131 157.2 XLON 00380193123TRLO0.1.1
28/11/2023 16:07:11 218 158.2 XLON 00380193201TRLO0.1.1
28/11/2023 16:07:54 5 157.2 XLON 00380193523TRLO0.1.1
28/11/2023 16:07:54 1699 157.2 XLON 00380193524TRLO0.1.1
28/11/2023 16:07:56 568 157 CHIX 00380193561TRLO0.1.1
28/11/2023 16:08:02 498 157.4 BATE 00380193601TRLO0.1.1
28/11/2023 16:21:47 502 157.4 XLON 00380201666TRLO0.1.1
28/11/2023 16:21:47 190 156.8 CHIX 00380201667TRLO0.1.1
28/11/2023 16:21:47 289 156.8 CHIX 00380201669TRLO0.1.1
28/11/2023 16:21:47 288 156.8 XLON 00380201670TRLO0.1.1
28/11/2023 16:21:47 848 156.8 XLON 00380201668TRLO0.1.1
28/11/2023 16:21:47 89 156.8 CHIX 00380201671TRLO0.1.1
28/11/2023 16:21:48 1000 157.2 BATE 00380201684TRLO0.1.1
28/11/2023 16:22:28 165 156.4 AQXE 00380202108TRLO0.1.1
28/11/2023 16:22:30 202 156.8 CHIX 00380202125TRLO0.1.1
28/11/2023 16:22:30 196 156.2 BATE 00380202126TRLO0.1.1
28/11/2023 16:22:33 1050 156.8 XLON 00380202182TRLO0.1.1
28/11/2023 16:22:33 317 156.8 XLON 00380202183TRLO0.1.1
28/11/2023 16:24:11 503 157.2 TRQX 00380203081TRLO0.1.1
28/11/2023 16:24:17 198 157 XLON 00380203129TRLO0.1.1
28/11/2023 16:24:23 197 157 XLON 00380203185TRLO0.1.1
28/11/2023 16:26:55 260 157.2 XLON 00380204605TRLO0.1.1
28/11/2023 16:26:55 537 157.2 CHIX 00380204609TRLO0.1.1
28/11/2023 16:29:41 473 157.2 XLON 00380206212TRLO0.1.1
28/11/2023 16:29:41 928 157.2 XLON 00380206213TRLO0.1.1
28/11/2023 16:29:42 1 157.2 XLON 00380206231TRLO0.1.1

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFLFSDLSLTFIV

Talk to a Data Expert

Have a question? We'll get back to you promptly.